中文
Press Release
Press Release
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
Jan 26, 2026
Cell Reports | Mabwell collaborates with SIOC, CAS and SJTU to publish research results on a monoclonal antibody targeting α-synuclein fibrils, revealing its potential to halt Parkinson’s disease progression

➞
Jan 21, 2026
Mabwell Announces First-Patient Dosed in Clinical Trial of Novel CDH17-Targeting ADC 7MW4911 in the U.S.

➞
Jan 06, 2026
SynuSight Biotech, an Incubated Company of Mabwell, and ABLi Therapeutics Enter into a License Agreement for [18F]-FD4 to Advance Clinical Research for Parkinson’s Disease

➞